Litigation Details for Celgene Corporation v. Amneal Pharmaceuticals LLC (D. Del. 2018)
✉ Email this page to a colleague
Celgene Corporation v. Amneal Pharmaceuticals LLC (D. Del. 2018)
Docket | ⤷ Sign Up | Date Filed | 2018-07-12 |
Court | District Court, D. Delaware | Date Terminated | 2018-10-10 |
Cause | 35:271 Patent Infringement | Assigned To | Richard Gibson Andrews |
Jury Demand | None | Referred To | |
Patents | 6,962,940; 7,427,638; 7,659,302; 7,893,101; 8,455,536; 9,018,243 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Celgene Corporation v. Amneal Pharmaceuticals LLC
Details for Celgene Corporation v. Amneal Pharmaceuticals LLC (D. Del. 2018)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2018-07-13 | 4 | Patent/Trademark Report to Commissioner of Patents | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,962,940 B2 ;7,427,638 B2 ;7,659,302…2018 10 October 2018 1:18-cv-01032 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
2018-10-11 | 7 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,962,940 B2; 7,427,638 B2; 7,659,302…2018 10 October 2018 1:18-cv-01032 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |